New Directions in the Study and Treatment of Metastatic Cancer

por Yoo, Byunghee, Fuchs, Bryan C., Medarova, Zdravka
Publicado 2018

The autotaxin-lysophosphatidic acid pathway emerges as a therapeutic target to prevent liver cancer

por Erstad, Derek J., Tager, Andrew M., Hoshida, Yujin, Fuchs, Bryan C.
Publicado 2017

Disease Biomarkers in Gastrointestinal Malignancies

por Moaven, Omeed, Raziee, Hamid, Bowne, Wilbur, Abbaszadegan, Mohammad Reza, Fuchs, Bryan C.
Publicado 2016

Hepatic stellate cells secrete Ccl5 to induce hepatocyte steatosis

por Kim, Byeong-Moo, Abdelfattah, Ahmed Maher, Vasan, Robin, Fuchs, Bryan C., Choi, Michael Y.
Publicado 2018

Author Correction: Hepatic stellate cells secrete Ccl5 to induce hepatocyte steatosis

por Kim, Byeong-Moo, Abdelfattah, Ahmed Maher, Vasan, Robin, Fuchs, Bryan C., Choi, Michael Y.
Publicado 2020

Human Fecal Bile Acid Analysis after Investigational Microbiota-Based Live Biotherapeutic Delivery for Recurrent Clostridioides difficile Infection

por Papazyan, Romeo, Ferdyan, Nicky, Srinivasan, Karthik, Gonzalez, Carlos, Shannon, William D., Blount, Ken, Fuchs, Bryan C.
Publicado 2023

Risk Factors, Pathogenesis, and Strategies for Hepatocellular Carcinoma Prevention: Emphasis on Secondary Prevention and Its Translational Challenges

por Li, Shen, Saviano, Antonio, Erstad, Derek J., Hoshida, Yujin, Fuchs, Bryan C., Baumert, Thomas, Tanabe, Kenneth K.
Publicado 2020

Mouse model of carbon tetrachloride induced liver fibrosis: Histopathological changes and expression of CD133 and epidermal growth factor

por Fujii, Tsutomu, Fuchs, Bryan C, Yamada, Suguru, Lauwers, Gregory Y, Kulu, Yakup, Goodwin, Jonathan M, Lanuti, Michael, Tanabe, Kenneth K
Publicado 2010

In vitro modeling of hepatocellular carcinoma molecular subtypes for anti-cancer drug assessment

por Hirschfield, Hadassa, Bian, C Billie, Higashi, Takaaki, Nakagawa, Shigeki, Zeleke, Tizita Z, Nair, Venugopalan D, Fuchs, Bryan C, Hoshida, Yujin
Publicado 2018

Cost-Effectiveness of Risk Score–Stratified Hepatocellular Carcinoma Screening in Patients with Cirrhosis

por Goossens, Nicolas, Singal, Amit G, King, Lindsay Y, Andersson, Karin L, Fuchs, Bryan C, Besa, Cecilia, Taouli, Bachir, Chung, Raymond T, Hoshida, Yujin
Publicado 2017

Oncolytic Herpes simplex virus expressing yeast cytosine deaminase: relationship between viral replication, transgene expression, prodrug bioactivation

por Yamada, Suguru, Kuroda, Toshihiko, Fuchs, Bryan C., He, Xiaoying, Supko, Jeffrey G., Schmitt, Anthony, McGinn, Christopher M., Lanuti, Michael, Tanabe, Kenneth K.
Publicado 2011

Pioglitazone Reduces Hepatocellular Carcinoma Development in Two Rodent Models of Cirrhosis

por Li, Shen, Ghoshal, Sarani, Sojoodi, Mozhdeh, Arora, Gunisha, Masia, Ricard, Erstad, Derek J., Lanuti, Michael, Hoshida, Yujin, Baumert, Thomas F., Tanabe, Kenneth K., Fuchs, Bryan C.
Publicado 2018

Molecular characterization of type I IFN-induced cytotoxicity in bladder cancer cells reveals biomarkers of resistance

por Green, Jennifer L., Osterhout, Robin E., Klova, Amy L., Merkwirth, Carsten, McDonnell, Scott R.P., Zavareh, Reza Beheshti, Fuchs, Bryan C., Kamal, Adeela, Jakobsen, Jørn S.
Publicado 2021

Prolonged cenicriviroc therapy reduces hepatic fibrosis despite steatohepatitis in a diet‐induced mouse model of nonalcoholic steatohepatitis

por Kruger, Annie J., Fuchs, Bryan C., Masia, Ricard, Holmes, Jacinta A., Salloum, Shadi, Sojoodi, Mozhdeh, Ferreira, Diego S., Rutledge, Stephanie M., Caravan, Peter, Alatrakchi, Nadia, Vig, Pam, Lefebvre, Eric, Chung, Raymond T.
Publicado 2018

Precision-Cut Liver Slices as an ex vivo model to evaluate antifibrotic therapies for liver fibrosis and cirrhosis

por Wang, Yongtao, Leaker, Ben, Qiao, Guoliang, Sojoodi, Mozhdeh, Eissa, Ibrahim Ragab, Epstein, Eliana T., Eddy, Jonathan, Dimowo, Oizoshimoshiofu, Lauer, Georg M., Chung, Raymond T., Qadan, Motaz, Lanuti, Michael, Fuchs, Bryan C., Tanabe, Kenneth K.
Publicado 2023

Orthotopic and heterotopic murine models of pancreatic cancer and their different responses to FOLFIRINOX chemotherapy

por Erstad, Derek J., Sojoodi, Mozhdeh, Taylor, Martin S., Ghoshal, Sarani, Razavi, Allen A., Graham-O'Regan, Katherine A., Bardeesy, Nabeel, Ferrone, Cristina R., Lanuti, Michael, Caravan, Peter, Tanabe, Kenneth K., Fuchs, Bryan C.
Publicado 2018

Improving the Therapeutic Efficacy of Sorafenib for Hepatocellular Carcinoma by Repurposing Disulfiram

por Zhang, Gong, Wang, Yufeng, Fuchs, Bryan C., Guo, Wei, Drum, David L., Erstad, Derek J., Shi, Baomin, DeLeo, Albert B., Zheng, Hui, Cai, Lei, Zhang, Liyuan, Tanabe, Kenneth K., Wang, Xinhui
Publicado 2022

The XBP1 Arm of the Unfolded Protein Response Induces Fibrogenic Activity in Hepatic Stellate Cells Through Autophagy

por Kim, Rosa S., Hasegawa, Daisuke, Goossens, Nicolas, Tsuchida, Takuma, Athwal, Varinder, Sun, Xiaochen, Robinson, Christopher L., Bhattacharya, Dipankar, Chou, Hsin-I, Zhang, David Y., Fuchs, Bryan C., Lee, Youngmin, Hoshida, Yujin, Friedman, Scott L.
Publicado 2016

Host Genetics Predict Clinical Deterioration in HCV-Related Cirrhosis

por King, Lindsay Y., Johnson, Kara B., Zheng, Hui, Wei, Lan, Gudewicz, Thomas, Hoshida, Yujin, Corey, Kathleen E., Ajayi, Tokunbo, Ufere, Nneka, Baumert, Thomas F., Chan, Andrew T., Tanabe, Kenneth K., Fuchs, Bryan C., Chung, Raymond T.
Publicado 2014

Transcriptome-based repurposing of apigenin as a potential anti-fibrotic agent targeting hepatic stellate cells

por Hicks, Daniel F., Goossens, Nicolas, Blas-García, Ana, Tsuchida, Takuma, Wooden, Benjamin, Wallace, Michael C., Nieto, Natalia, Lade, Abigale, Redhead, Benjamin, Cederbaum, Arthur I, Dudley, Joel T., Fuchs, Bryan C., Lee, Youngmin A., Hoshida, Yujin, Friedman, Scott L.
Publicado 2017